Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Impact BioMedicalIBO -1.57%10 Days Inventory is 5,703.13 as of Jun. 2026, which is 10417% above its 10-year median of 54.23. GuruFocus rates IBO with a GF Score™ of 10/100. The stock has 6 warning signs investors should review. Among 638 Biotechnology companies, Impact BioMedical ranks worse than 55.17% on this metric.
The historical rank and industry rank for Impact BioMedical's Days Inventory or its related term are showing as below:
IBO'
s Days Inventory Range Over the Past 10 Years
Min: 54.23 Med: 54.23 Max: 199.54
Current: 199.54
During the past 7 years, Impact BioMedical's highest Days Inventory was 199.54. The lowest was 54.23. And the median was 54.23.
IBO's Days Inventory is ranked worse than 55.17% of 638
companies
in the Biotechnology industry
Industry Median: 181.695
vs IBO: 199.54
Impact BioMedical's Days Inventory
declined
from Jun. 2025 (44,484.38) to Jun. 2026 (5,703.13).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Impact BioMedical's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.02.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Impact BioMedical's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 20.83.
Impact BioMedical (AMEX:IBO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Impact BioMedical's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Impact BioMedical's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Impact BioMedical Days Inventory Related Terms
Impact BioMedical Days Inventory Historical Data
* Premium members only.
The historical data trend for Impact BioMedical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Impact BioMedical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Impact BioMedical Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Impact BioMedical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Impact BioMedical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Impact BioMedical (IBO) has a Days Inventory of 5,703.13 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Impact BioMedical and its competitors. This is 10417% above median its historical median of 54.23. Over the past decade, Impact BioMedical's Days Inventory has ranged from 54.23 to 199.54. According to the industry distribution chart, Impact BioMedical ranks #352 out of 638 companies in the Biotechnology industry, placing it in the top 55.2%.
Is Impact BioMedical's Days Inventory too high?
Impact BioMedical's current Days Inventory of 5,703.13 is 10417% above median its 10-year median of 54.23. Over the past 10 years, this metric has ranged from a low of 54.23 to a high of 199.54. The Biotechnology industry median Days Inventory is 181.70. Impact BioMedical's value of 5,703.13 is 3038.8% above this industry median. Based on the distribution chart, Impact BioMedical ranks #352 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Impact BioMedical has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Impact BioMedical's Days Inventory compare to ATYR and MCRB?
According to the Biotechnology industry distribution chart, Impact BioMedical ranks #352 out of 638 companies for Days Inventory. This places Impact BioMedical in the lower half of its industry. The industry median Days Inventory is 181.70. Impact BioMedical's value of 5,703.13 is 3038.8% above this benchmark. Historically, Impact BioMedical's own Days Inventory has ranged from 54.23 to 199.54 over the past decade. While the company's 10-year median is 54.23 vs. the industry median of 181.70, Impact BioMedical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 181.70, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Impact BioMedical's current Days Inventory of 5,703.13 is 3038.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Impact BioMedical and its competitors. For the Biotechnology industry, the median Days Inventory is 181.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Impact BioMedical's current Days Inventory is 5,703.13, which is 10417% above median its own 10-year median of 54.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impact BioMedical stock overvalued right now?
Impact BioMedical (IBO) has a current Days Inventory of 5,703.13. The current Days Inventory is 5,703.13, which is 10417% above median its 10-year median of 54.23 and 3038.8% above the Biotechnology industry median of 181.70. Impact BioMedical's overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Impact BioMedical (IBO), the current Days Inventory is 5,703.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
10GF Score
Get the complete analysis for IBO
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IBO has been successfully added to your 
